286 related articles for article (PubMed ID: 24269007)
1. Vertebral osteomyelitis caused by vancomycin-tolerant methicillin-resistant Staphylococcus aureus bacteremia: Experience with teicoplanin plus fosfomycin combination therapy.
Lee WS; Chen YC; Chen HP; Chen TH; Cheng CY
J Microbiol Immunol Infect; 2016 Aug; 49(4):600-3. PubMed ID: 24269007
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
Uçkay I; Bernard L; Buzzi M; Harbarth S; François P; Huggler E; Ferry T; Schrenzel J; Renzoni A; Vaudaux P; Lew DP
Antimicrob Agents Chemother; 2012 Mar; 56(3):1258-64. PubMed ID: 22155824
[TBL] [Abstract][Full Text] [Related]
3. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).
Gould IM
Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S17-21. PubMed ID: 23664580
[TBL] [Abstract][Full Text] [Related]
6. Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.
Aspinall SL; Friedland DM; Yu VL; Rihs JD; Muder RR
Ann Pharmacother; 1995; 29(7-8):694-7. PubMed ID: 8520082
[TBL] [Abstract][Full Text] [Related]
7. The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection.
McNeil JC; Kaplan SL; Vallejo JG
Pediatr Infect Dis J; 2017 Jun; 36(6):572-577. PubMed ID: 28027279
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.
Poeppl W; Lingscheid T; Bernitzky D; Schwarze UY; Donath O; Perkmann T; Kozakowski N; Plasenzotti R; Reznicek G; Burgmann H
Antimicrob Agents Chemother; 2014 Sep; 58(9):5111-6. PubMed ID: 24936591
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
[TBL] [Abstract][Full Text] [Related]
11. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
[TBL] [Abstract][Full Text] [Related]
12. Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to Vancomycin by adding fosfomycin: a case report.
Linasmita P
J Med Assoc Thai; 2012 Jul; 95(7):960-3. PubMed ID: 22919993
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis.
Gelfand MS; Cleveland KO
South Med J; 2004 Jun; 97(6):593-7. PubMed ID: 15255429
[TBL] [Abstract][Full Text] [Related]
14. Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia.
Yoon YK; Park DW; Sohn JW; Kim HY; Kim YS; Lee CS; Lee MS; Ryu SY; Jang HC; Choi YJ; Kang CI; Choi HJ; Lee SS; Kim SW; Kim SI; Kim ES; Kim JY; Yang KS; Peck KR; Kim MJ
Antimicrob Agents Chemother; 2014; 58(1):317-24. PubMed ID: 24165181
[TBL] [Abstract][Full Text] [Related]
15. Multiple Weekly Dalbavancin Dosing for the Treatment of Native Vertebral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus Aureus: A Case Report.
Almangour TA; Fletcher V; Alessa M; Alhifany AA; Tabb D
Am J Case Rep; 2017 Dec; 18():1315-1319. PubMed ID: 29222405
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
Park KH; Chong YP; Kim SH; Lee SO; Choi SH; Lee MS; Jeong JY; Woo JH; Kim YS
J Infect; 2013 Dec; 67(6):556-64. PubMed ID: 23916563
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.
Poeppl W; Tobudic S; Lingscheid T; Plasenzotti R; Kozakowski N; Georgopoulos A; Burgmann H
Antimicrob Agents Chemother; 2011 Feb; 55(2):931-3. PubMed ID: 21098253
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
19. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH
J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187
[TBL] [Abstract][Full Text] [Related]
20. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
